.gamma.-RAR antagonist ligand or .alpha.-RAR agonist ligand as an apoptosis inhibitor
US6063797A · kind A · utility
18Cited by
3References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 1998 |
| Grant date | May 16, 2000 |
| Priority date | — |
| Expiry date | Jul 15, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of a combination of an alpha RAR receptor-specific agonist ligand and a gamma RAR receptor-specific antagonist ligand to reduce the rate of apoptosis is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.